171
Views
7
Downloads
0
Crossref
N/A
WoS
0
Scopus
0
CSCD
Stem cell therapy is a promising treatment for neurogenerative disease as well as inflammatory and immune mediated diseases. Decades of preclinical research has demonstrated stem cell ability to differentiate into multiple cell lineages and be utilised in regeneration and repair with their immunomodulatory and immunosuppressive properties. This work has provided the fundamental scientific knowledge needed to launch various clinical trials studying stem cell therapy in autoimmune disorders, stroke, and other tissue injury. Despite the early success many of these promising therapies are yet to breakthrough into clinical use. In this review, we highlight the recent developments in the use of stem cells as therapeutic agents for neurological conditions as well as their failures and how the clinical translation can be improved.
Stem cell therapy is a promising treatment for neurogenerative disease as well as inflammatory and immune mediated diseases. Decades of preclinical research has demonstrated stem cell ability to differentiate into multiple cell lineages and be utilised in regeneration and repair with their immunomodulatory and immunosuppressive properties. This work has provided the fundamental scientific knowledge needed to launch various clinical trials studying stem cell therapy in autoimmune disorders, stroke, and other tissue injury. Despite the early success many of these promising therapies are yet to breakthrough into clinical use. In this review, we highlight the recent developments in the use of stem cells as therapeutic agents for neurological conditions as well as their failures and how the clinical translation can be improved.
Aboody KS, Najbauer J, Metz MZ, D'Apuzzo M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats RA, Garcia E, Aramburo S, Valenzuela VV, Frank RT, Barish ME, Brown CE, Kim SU, Badie B, Portnow J (2013) Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. Sci Transl Med 5(184): 184ra59. https://doi.org/10.1126/scitranslmed.3005365
Acosta SA, Tajiri N, Hoover J, Kaneko Y (2015) Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke. Stroke 46(9): 2616−2627
Ahmed AS, Sheng MH, Wasnik S, Baylink DJ, Lau KW (2017) Effect of aging on stem cells. World J Exp Med 7(1): 1−10
Bang OY (2016) Clinical trials of adult stem cell therapy in patients with ischemic stroke. J Clin Neurol 12(1): 14−20
Boehme A, Esenwa C, Elkind M (2017) Stroke risk factors, genetics, and prevention. Circ Res 120(3): 472−495
Cho S-W, Kim S-S, Won Rhie J, Mi Cho H, Yong Choi C, Kim B-S (2005) Engineering of volume-stable adipose tissues. Biomaterials 26(17): 3577−3585
Christiaens V, Lijnen HR (2010) Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 318(1): 2−9
Coccè V, Farronato D, Brini A, Masia C, Giannì A, Piovani G, Sisto F, Alessandri G, Angiero F, Pessina A (2017) Drug loaded gingival mesenchymal stromal cells (GinPa-MSCs) inhibit in vitro proliferation of oral squamous cell carcinoma. Sci Rep 7(1): 9376. https://doi.org/10.1038/s41598-017-09175-4
Coccè V, Franzè S, Brini AT, Giannì AB, Pascucci L, Ciusani E, Alessandri G, Farronato G, Cavicchini L, Sordi V, Paroni R, Cas MD, Cilurzo F, Pessina A (2019) In vitro anticancer activity of extracellular vesicles (EVs) secreted by gingival mesenchymal stromal cells primed with paclitaxel. Pharmaceutics 11(2): 61. https://doi.org/10.3390/pharmaceutics11020061
Eyrich D, Göpferich A, Blunk T (2006) Fibrin in tissue engineering. Adv Exp Med Biol 585: 379−392
Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA (2018) Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering. Stem Cell Int 2018: 8031718. https://doi.org/10.1155/2018/8031718
Gesta S, Tseng Y-H, Kahn CR (2008) Developmental origin of fat: tracking obesity to its source. Cell 135(2): 366−366
Gomillion CT, Burg KJL (2006) Stem cells and adipose tissue engineering. Biomaterials 27(36): 6052−6063
Göpferich A (1996) Mechanisms of polymer degradation and erosion. Biomaterials 17(2): 103−114
Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J (2019) Mesenchymal stem cells for regenerative medicine. Cells 8(8): 886. https://doi.org/10.3390/cells8080886
Hossain J, Latif MA, Ystaas LAR, Ninzima S, Riecken K, Muller A, Azuaje F, Vareecal Joseph J, Talasila KM, Ghimire J, Fehse B, Bjerkvig R, Miletic H (2019) Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro Oncol 21(7): 890−900
Hsuan YCY, Lin CH, Chang CP, Lin MT (2016) Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav 6(10): 1−11
Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y (1998) De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 95(3): 1062−1066
Kimura Y, Ozeki M, Inamoto T, Tabata Y (2002) Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng 8(4): 603−613
Kievit E, Bershad E, Ng E, Sethna P, Dev I, Lawrence TS, Rehemtulla A (1999) Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 59(7): 1417−1421
Korkegian A, Black ME, Baker D, Stoddard BL (2005) Computational thermostabilization of an enzyme. Science 308(5723): 857−860
Koton S, Telman G, Kimiagar I, Tanne D (2013) Gender differences in characteristics, management and outcome at discharge and three months after stroke in a national acute stroke registry. Int J Cardiol 168(4): 4081−4084
Koyuncu S, Irmak D, Saez I, Vilchez D (2015) Defining the general principles of stem cell aging: lessons from organismal models. Curr Stem Cell Rep 1: 162−169
Kurtzberg J, Prasad V, Grimley M, Horn B, Carpenter P, Jacobsohn D, Prockop S (2010) Allogeneic human mesenchymal stem cell therapy (Prochymal®) as a rescue agent for severe treatment resistant GVHD in pediatric patients. Biol Blood Marrow Transplant 16: S169. https://doi.org/10.1016/j.bbmt.2009.12.056
Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H (2005) Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 12(7): 600−607
Li J, Mooney D (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater 1(12): 16071. https://doi.org/10.1038/natrevmats.2016.71
Miana VV, Prieto González EA (2018) Adipose tissue stem cells in regenerative medicine. Ecancer 12: 822. https://doi.org/10.3332/ecancer.2018.822
Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, Cadei M, Soldati G, Pessina A, Parati E, Slevin M, Alessandri G (2019) Long-lasting anti-inflammatory activity of human microfragmented adipose tissue. Stem Cell Int 2019: 5901479. https://doi.org/10.1155/2019/5901479
Momin EN, Mohyeldin A, Zaidi HA, Vela G, Quinones-Hinojosa A (2010) Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther 5(4): 326−344
Oberbauer E, Steffenhagen C, Wurzer C, Gabriel C, Redl H, Wolbank S (2015) Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. Cell Regen 4: 7. https://doi.org/10.1186/s13619-015-0020-0
Panchal J, Malanga G, Sheinkop M (2018) Safety and efficacy of percutaneous injection of lipogems micro-fractured adipose tissue for osteoarthritic knees. Am J Orthop (Belle Mead NJ) 47(11). https://doi.org/10.12788/ajo.2018.0098
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators (2018) Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease. Gastroenterology 154(5): 1334−1342
Patrick JCW, Chauvin PB, Hobley J, Reece GP (1999) Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Eng 5(2): 139−151
Popa-Wagner A, Buga A, Doeppner T, Hermann D (2014) Stem cell therapies in preclinical models of stroke associated with aging. Front Cell Neurosci 8: 347. https://doi.org/10.3389/fncel.2014.00347
Popa-Wagner A, Petcu E, Capitanescu B, Hermann D, Radu E, Gresita A (2020) Ageing as a risk factor for cerebral ischemia: underlying mechanisms and therapy in animal models and in the clinic. Mech Ageing Dev 190: 111312. https://doi.org/10.1016/j.mad.2020.111312
Randelli P, Menon A, Ragone V, Creo P, Bergante S, Randelli F, De Girolamo L, Alfieri Montrasio U, Banfi G, Cabitza P, Tettamanti G, Anastasia L (2016) Lipogems product treatment increases the proliferation rate of human tendon stem cells without affecting their stemness and differentiation capability. Stem Cells Int 2016: 4373410. https://doi.org/10.1155/2016/4373410
Roato I, Mussano F, Reano S, Boriani F, Margara A, Ferracini R, Adriani E, SabryO, Fiorini M, Fattori P (2020) A novel method to optimize autologous adipose tissue recovery with extracellular matrix preservation. Processes 8(1): 88. https://doi.org/10.3390/pr8010088
Srijaya T C, Ramasamy TS, Kasim NHA (2014) Advancing stem cell therapy from bench to bedside: lessons from drug therapies. J Transl Med 12: 243. https://doi.org/10.1186/s12967-014-0243-9
Tatarishvili J, Okia K, Monnia E, Kochb P, Memanishvilia T, Bugad AM, Vermaa V, Popa-Wagnerd A, Brustleb O, Lindvallaand O, Kokaiaa Z (2014) Human induced pluripotent stem cellsimprove recovery in stroke-injured aged rats. Restor Neurol Neurosci 32(4): 547−558
Tremolada C, Colombo V, Ventura C (2016) Adipose tissue and mesenchymal stem cells: state of the art and Lipogems® technology development. Curr Stem Cell Rep 2(3): 304−312
Trivisonno A, Alexander RW, Baldari S, Cohen SR, Di Rocco G, Gentile P, Magalon G, Magalon J, Miller RB, Womack H, Toietta G (2019) Intraoperative strategies for minimal manipulation of autologous adipose tissue for cell- and tissue-based therapies: concise review. Stem Cells Transl Med 8(12): 1265−1271
Tsuji W, Inamoto T, Yamashiro H, Ueno T, Kato H, Kimura Y, Tabata Y, Toi M (2009) Adipogenesis induced by human adipose tissue-derived stem cells. Tissue Eng 15(1): 83−93
von Heimburg D, Zachariah S, Kühling H, Heschel I, Schoof H, Hafemann B, Pallua N (2001) Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and in vivo. Biomaterials 22(5): 429−438
Walton RL, Beahm K, Wu L (2004) De novo adipose formation in a vascularized engineered construct. Microsurgery 24(5): 378−384
Zeira O, Scaccia S, Pettinari L, Ghezzi E, Asiag N, Martinelli L, Zahirpour D, Dumas M, Konar M, Lupi D, Fiette L, Pascucci L, Leonardi L, Cliff A, Alessandri G, Pessina A, Spaziante D, Aralla M (2018) Intra-Articular administration of autologous micro-fragmented adipose tissue in dogs with spontaneous osteoarthritis: safety, feasibility, and clinical outcomes. Stem Cells Transl Med 7(11): 819−828
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.